Share chart Theravance Biopharma, Inc.
Extended chart
Simple chart
About Theravance Biopharma, Inc.
Биофармацевтическая компания Theravance Biopharma, Inc. занимается открытием, разработкой и коммерциализацией респираторных препаратов в США и Европе. Компания предлагает YUPELRI, антагонист мускариновых рецепторов длительного действия, предназначенный для распыления один раз в день для лечения хронической обструктивной болезни легких (ХОБЛ). Продукт компании включает ампрелоксетин, исследуемый ингибитор обратного захвата норадреналина, который завершил исследование фазы III нейрогенной ортостатической гипотензии; и TRELEGY для лечения ХОБЛ и астмы. more details| IPO date | 2014-05-16 |
|---|---|
| ISIN | KYG8807B1068 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.theravance.com |
| Цена ао | 9.3 |
| Change price per day: | 0% (8.4) |
|---|---|
| Change price per week: | -0.1189% (8.41) |
| Change price per month: | -9.48% (9.28) |
| Change price per 3 month: | -1.98% (8.57) |
| Change price per half year: | -2.33% (8.6) |
| Change price per year: | -15.32% (9.92) |
| Change price per 3 year: | -12.13% (9.56) |
| Change price per 5 year: | -53.23% (17.96) |
| Change price per year to date: | -13.49% (9.71) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Principal Healthcare Innovators ETF | 0.0367 | 618.5 | 0.8416 |
| Future Tech ETF | 0.0367 | 426.34 | 0.8416 |
| 0.04 | 522.42 | 0.84 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Rick E. Winningham M.B.A. | Chairman & CEO | 1.78M | 1960 (65 years) |
| Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs | 942.81k | 1965 (60 years) |
| Mr. Aziz Sawaf C.F.A. | Senior VP & CFO | N/A | 1982 (43 years) |
| Ms. Gail B. Cohen | Vice President of Corporate Communications & Investor Relations | N/A | |
| Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary | N/A | 1974 (51 year) |
| Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer | N/A | |
| Dr. Aine Miller Ph.D. | SVP of Dev., VP of Regu., Quality, Clinical Safety & Pharmacovigilance and Head of Ireland Office | N/A | |
| Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
Address: Cayman Islands, George Town KY-, Ugland House - open in Google maps, open in Yandex maps
Website: https://www.theravance.com
Website: https://www.theravance.com
